#SABCSSnippets: Virginia Kaklamani talked with Laura Esserman about the results of the WISDOM 1.0 study, which demonstrated that risk-based breast cancer screening is safe, preferred by women, and identifies the highest risk individuals. buff.ly/DFByGvB @vkaklamani.bsky.social

Highlight of #sabcs25 was the wisdom trial. Here we discuss results with @drlauraesserman.bsky.social brnw.ch/21wYnp5

Take a look back at #SABCS24! Thank you to the co-directors, executive committee, program planning committee, speakers, and attendees for making this year's symposium a tremendous success. @uthealthsamda.bsky.social @theaacr.bsky.social

Padma trial confirms that no role of chemo in first line chemo in HR+ HER2- MBC. Great data. #sabcs24. @sabcs.bsky.social

Thank you all for coming out and starting #sabcs24 with some tennis on a beautiful day in #sanantonio @breastcancerdoc.bsky.social @erikahilton.bsky.social @sabcs.bsky.social